MLICM
ANTH

Metropolitan Life Insurance Company (MetLife)’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ANTH Stock Details ANTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-3,351
Closed -$124K – 2551
2015
Q4 		$124K Hold
3,351
– – ﹤0.01% 2482
2015
Q3 		$163K Sell
3,351
-43
-1% -$3K ﹤0.01% 2423
2015
Q2 		$234K Buy
+3,394
New +$157K ﹤0.01% 2300

Other funds holding ANTH

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s ANTH Position: Q1 2016 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q1 2016, closing a stake of 3,351 shares — an estimated $124K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ANTH in Q2 2015 and held it in 3 quarters. The position peaked at $234K in Q2 2015. 72 funds tracked by Wall St. Rank hold ANTH as of Q1 2016.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Anthera Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 3,351 Anthera Pharmaceuticals, Inc. shares in Q1 2016, an estimated $124K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Anthera Pharmaceuticals, Inc. in Q2 2015 and held it in 3 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Anthera Pharmaceuticals, Inc. position peaked at $234K in Q2 2015.
  • 72 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q1 2016.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2016, filed 16 May 2016.